Have not dug into it in all that much depth either, but Jalali was one of the first and loudest proponents of theories of SARS-CoV-2 being primarily an issue of vascular (as opposed to respiratory) pathologies, and fluvoxamine as a form of treatment which, while not a cure, did wind up being shown to be somewhat effective.

From the little bit I saw it seemed like maybe he was recommending aggressive use of antihistamines. I believe some of it may have been incorporated into the FLCCC IRECOVER protocol.

The other thing that he seemed to believe might work is anticoagulants, but he was concerned that the doses that would need to be taken are potentially hazardous in and of themselves.